FDA.report

Application 088488

Type
ANDA
Sponsor
BARR

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001HYDROXYZINE PAMOATEHYDROXYZINE PAMOATECAPSULE;ORALEQ 100MG HYDROCHLORIDENoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
0555-0324Hydroxyzine PamoateHydroxyzine PamoateTeva Pharmaceuticals USA, Inc.ANDACurrent
43063-251Hydroxyzine PamoateHydroxyzine PamoatePD-Rx Pharmaceuticals, Inc.ANDACurrent
53808-0431Hydroxyzine PamoateHYDROXYZINE PAMOATEState of Florida DOH Central PharmacyANDACurrent
63629-9244Hydroxyzine PamoateHydroxyzine PamoateBryant Ranch PrepackANDACurrent
70518-2769Hydroxyzine PamoateHydroxyzine PamoateREMEDYREPACK INC.ANDACurrent
70518-2769Hydroxyzine PamoateHydroxyzine PamoateREMEDYREPACK INC.ANDACurrent